Johnson & Johnson

Nov 05, 09 NEW STORY 09:00 ET Johnson & Johnson to Participate in Credit Suisse 18th Annual Health Care Conference   Nov 03, 09 07:30 ET Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth   Oct 22, 09 10:10 ET Xerox Chairman Anne M. Mulcahy Appointed to Johnson & Johnson Board of Directors   Oct 13, 09 07:45 ET Johnson & Johnson Reports 2009 Third-Quarter Results:   Oct 06, 09 15:02 ET Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Business   Sep 28, 09 01:45 ET Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment   Sep 17, 09 09:00 ET Johnson & Johnson and Elan Corporation plc Announce Closing of Transaction Related to Alzheimer's Immunotherapy Program and Equity Investment   Sep 08, 09 15:23 ET Johnson & Johnson to Participate in Morgan Stanley Global Healthcare Unplugged Conference   Jul 14, 09 07:45 ET Johnson & Johnson Reports 2009 Second-Quarter Results:   Jul 10, 09 10:56 ET Johnson & Johnson Completes Acquisition of Cougar Biotechnology   Jul 07, 09 09:15 ET Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results   Jul 03, 09 08:53 ET Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology   Jul 02, 09 07:57 ET Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment   Jun 17, 09 17:32 ET Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology   Jun 05, 09 09:00 ET Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology   Jun 04, 09 08:00 ET Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs   May 27, 09 17:58 ET Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)   09:38 ET Johnson & Johnson to Host Pharmaceutical Business Review   May 21, 09 19:06 ET Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.   May 13, 09 09:30 ET Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference   May 12, 09 09:30 ET Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I   May 07, 09 12:00 ET Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009   May 05, 09 12:35 ET Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference   Apr 23, 09 10:23 ET Johnson & Johnson Announces Dividend Increase of 6.5%   Apr 16, 09 12:52 ET Johnson & Johnson to Webcast Annual Meeting of Shareholders   Apr 14, 09 07:45 ET Johnson & Johnson Reports 2009 First-Quarter Results:   Apr 07, 09 09:09 ET Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results   Mar 12, 09 11:57 ET Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress   Mar 10, 09 09:29 ET Johnson & Johnson to Participate in the 29th Annual Cowen & Company Health Care Conference   Jan 23, 09 17:06 ET Johnson & Johnson Completes Acquisition of Mentor Corporation   09:15 ET Johnson & Johnson Completes Tender Offer for Mentor Corporation   Jan 20, 09 07:45 ET Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results   Jan 17, 09 09:55 ET Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered   Jan 15, 09 14:00 ET Johnson & Johnson Announces Satisfaction of Regulatory Clearances Condition for its Proposed Acquisition of Mentor Corporation   13:23 ET Court of Appeals Overturns 2005 Patent Verdict Against Cordis   Jan 13, 09 11:44 ET Johnson & Johnson to Review Fourth-Quarter and Full-Year 2008 Financial Results   Jan 06, 09 17:22 ET Johnson & Johnson Extends Tender Offer for Mentor Corporation   Dec 30, 08 16:05 ET Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.   Dec 27, 08 10:08 ET Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.   Dec 19, 08 17:42 ET Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.   14:31 ET Johnson & Johnson Strengthens Wellness & Prevention Platform with Acquisition of Human Performance Institute(TM)   Dec 12, 08 08:30 ET Johnson & Johnson Begins Tender Offer to Acquire Mentor Corporation   Dec 11, 08 17:40 ET Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix   Dec 01, 08 08:00 ET Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation   Nov 25, 08 12:38 ET Johnson & Johnson Begins Tender Offer to Acquire Omrix   Nov 24, 08 06:30 ET Johnson & Johnson Announces Definitive Agreement to Acquire Omrix   Nov 06, 08 15:14 ET Johnson & Johnson to Participate in Credit Suisse 2008 Health Care Conference   Oct 27, 08 15:10 ET Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.   Oct 14, 08 07:45 ET Johnson & Johnson Reports 2008 Third-Quarter Results:   Oct 09, 08 10:15 ET Johnson & Johnson Announces Executive Appointments: Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky, Worldwide Chairman, Surgical Care Group   Oct 07, 08 11:20 ET Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business   Sep 30, 08 18:28 ET U.S. District Court in Delaware Enters Final Judgment of Approximately $1.2 Billion to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation   Sep 15, 08 14:47 ET U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation   Sep 12, 08 07:02 ET Christine A. Poon Plans Retirement from Johnson & Johnson in Early 2009   Jul 15, 08 07:53 ET Johnson & Johnson Reports 2008 Second-Quarter Results:   Jul 10, 08 09:02 ET Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals   Jul 08, 08 09:30 ET Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results   Jun 17, 08 15:16 ET Johnson & Johnson and American Red Cross Announce Resolution of Lawsuit   Jun 06, 08 10:35 ET Johnson & Johnson to Participate in 29th Annual Goldman Sachs Global Healthcare Conference   Jun 05, 08 09:30 ET Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses   May 29, 08 10:36 ET Johnson & Johnson to Host Medical Devices & Diagnostics and Consumer Business Review   May 15, 08 11:09 ET Johnson & Johnson to Participate in Citi's Global Healthcare Conference   May 07, 08 10:20 ET Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting   Apr 29, 08 15:04 ET Johnson & Johnson to Participate in Deutsche Bank Health Care Conference   Apr 25, 08 10:08 ET Johnson & Johnson to Participate in Morgan Stanley Conference   Apr 24, 08 10:24 ET Johnson & Johnson Announces Dividend Increase of 10.8%   Apr 22, 08 08:21 ET Johnson & Johnson to Webcast Annual Meeting of Shareholders   Apr 15, 08 08:16 ET Johnson & Johnson Reports 2008 First-Quarter Results:   Apr 08, 08 09:53 ET Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results   Mar 13, 08 09:04 ET Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference   Mar 11, 08 11:17 ET Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference   Mar 03, 08 10:48 ET Johnson & Johnson and NBC Olympics Partner to Share the Stories of U.S. Olympic Hopefuls and Their Journeys to Beijing With The Family Room      Feb 27, 08 09:59 ET DePuy to Host Analyst Meeting   Jan 22, 08 07:44 ET Johnson & Johnson Reports Fourth-Quarter and Full-Year 2007 Results   Jan 15, 08 10:24 ET Johnson & Johnson to Review Fourth-Quarter and Full-Year 2007 Financial Results   Jan 07, 08 15:26 ET Court of Appeals Upholds Verdicts in Favor of Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation   Nov 15, 07 09:24 ET Johnson & Johnson Announces Changes to Accelerate Growth   Nov 07, 07 09:54 ET UCLA Research Shows Dramatic Savings for Medicaid When Head Start Parents Learn to Care for Kids' Illnesses   Nov 06, 07 15:40 ET Johnson & Johnson to Present at the Credit Suisse 2007 Healthcare Conference   Nov 01, 07 11:18 ET Johnson & Johnson to Host Analyst Meeting to Discuss Three Late-Stage Pipeline Compounds Presented at American College of Rheumatology (ACR) Conference   Oct 16, 07 07:49 ET Johnson & Johnson Reports 2007 Third-Quarter Results: Sales of $15.0 Billion Increased 12.7%; EPS was $.88, Including Special Charges; Excluding Special Charges, EPS was $1.06 *   Oct 10, 07 09:47 ET Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Its Medical Device & Diagnostics Business   Sep 27, 07 14:52 ET Statement of DePuy Orthopaedics, Inc. Regarding Agreement with U.S. Attorney's Office   Sep 04, 07 12:17 ET Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference   Jul 31, 07 07:00 ET Johnson & Johnson Plans to Improve Overall Cost Structure, While Continuing to Invest in Opportunities for Sustained Profitable Growth   Jul 17, 07 07:34 ET Johnson & Johnson Reports 2007 Second-Quarter Results: Sales Increase of 13.2% and EPS increase of 10.5% Versus a Year Ago; Excluding Special Charges in 2006, EPS increased 7.1%*   Jul 11, 07 10:17 ET Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results   Jul 09, 07 11:53 ET Johnson & Johnson Announces $10 Billion Share Repurchase Program   Jun 12, 07 13:02 ET William D. Perez of Wm. Wrigley Jr. Company Appointed to Johnson & Johnson Board of Directors   Jun 07, 07 12:53 ET Johnson & Johnson Highlights Growth Strategies for Pharmaceutical and Consumer Businesses   May 29, 07 15:03 ET Johnson & Johnson To Host Pharmaceutical and Consumer Business Review   May 21, 07 15:07 ET Johnson & Johnson to Participate in Bank of America 2007 Health Care Conference   May 16, 07 15:16 ET Johnson & Johnson to Participate in Citigroup's Global Healthcare Conference   11:03 ET Cordis To Host Analyst Meeting At EuroPCR 2007   May 07, 07 06:59 ET Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions   May 04, 07 15:57 ET Ortho-Clinical Diagnostics, Inc. Issues Voluntary, Nationwide Recall for Cardiac Marker   Apr 27, 07 10:09 ET Johnson & Johnson to Participate in Morgan Stanley Conference   Apr 26, 07 10:31 ET Johnson & Johnson Announces Dividend Increase of 10.7%   Apr 19, 07 15:15 ET Johnson & Johnson to Host Annual Meeting of Shareholders   Apr 17, 07 08:00 ET Johnson & Johnson Reports 2007 First-Quarter Results: Sales Increase of 15.7% and EPS of $.88 Versus $1.10 a Year Ago; Excluding Special Items, EPS was $1.16, an increase of 17.2% *   Apr 11, 07 10:11 ET Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results   Mar 13, 07 13:24 ET Johnson & Johnson to Participate in Lehman Brothers Tenth Annual Global Healthcare Conference   Mar 12, 07 09:00 ET Johnson & Johnson Receives Subpoenas   Mar 07, 07 11:46 ET Johnson & Johnson to Participate in the 27th Annual Cowen & Company Health Care Conference   Feb 12, 07 18:36 ET Johnson & Johnson Statement on Voluntary Disclosure   Feb 01, 07 16:19 ET Johnson & Johnson Completes Acquisition of Conor Medsystems, Inc.   Jan 23, 07 08:18 ET Johnson & Johnson Reports Fourth-Quarter and Full-Year 2006 Results   Jan 17, 07 09:58 ET Johnson & Johnson to Review Fourth-Quarter and Full-Year 2006 Financial Results   Dec 20, 06 17:34 ET Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare   Dec 12, 06 18:12 ET Johnson & Johnson Acquisition of Pfizer Consumer Healthcare Receives Clearance from U.S. Federal Trade Commission (FTC)   Nov 16, 06 19:43 ET Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.   Oct 17, 06 08:00 ET Johnson & Johnson Reports 2006 Third-Quarter Results: Sales Increase of 7.9% and EPS of $.94 Versus $.85 a Year Ago; Excluding In-Process Research and Development Charges, EPS Increased 15.3% *   Oct 16, 06 15:27 ET Cordis to Host Analyst Meeting at TCT Conference   Oct 10, 06 10:30 ET Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Results   Oct 06, 06 16:20 ET Robert J. Darretta to Retire as Vice Chairman and CFO of Johnson & Johnson   Sep 13, 06 16:09 ET Johnson & Johnson to Participate in Merrill Lynch Conference   Sep 07, 06 15:44 ET Johnson & Johnson to Participate in the Bear Stearns 19th Annual Health Care Conference   Aug 29, 06 13:55 ET Johnson & Johnson to Host Medical Devices & Diagnostics Business Review   Jul 18, 06 08:15 ET Johnson & Johnson Reports 2006 Second-Quarter EPS Increase of 10.5% on Sales Increase of 4.7%   Jul 12, 06 11:53 ET Johnson & Johnson to Host Analyst Meeting to Discuss Second-Quarter Financial Results; Review Pharmaceuticals Business/Pipeline and the Planned Acquisition of Pfizer Consumer Healthcare   Jun 26, 06 06:01 ET Johnson & Johnson to Acquire Pfizer Consumer Healthcare; Combination Creates World's Premier Consumer Health Care Company   Jun 08, 06 11:36 ET Johnson & Johnson to Participate in Goldman Sachs Conference   May 11, 06 17:08 ET District Court Issues Two Decisions Regarding Patent Litigation Between Cordis Corporation and Boston Scientific   12:36 ET Johnson & Johnson to Participate in the Banc of America Securities Health Care Conference 2006   May 10, 06 14:28 ET Pharmaceutical Operating Companies of Johnson & Johnson Continue Patient Assistance for Eligible Medicare Beneficiaries   Apr 27, 06 14:46 ET Johnson & Johnson to Participate in Morgan Stanley Conference   10:57 ET Johnson & Johnson Announces Dividend Increase of 13.6%   Apr 24, 06 11:03 ET Johnson & Johnson to Host Annual Meeting of Shareholders   Apr 18, 06 08:00 ET Johnson & Johnson Reports 2006 First-Quarter EPS Rose 17.0% on Sales Increase of 1.2%   Apr 11, 06 14:51 ET Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results   Mar 31, 06 17:08 ET Ortho-Clinical Diagnostics Issues a Voluntary Product Recall for VITROS(R) Immunodiagnostic Products Signal Reagent   Mar 28, 06 14:45 ET Johnson & Johnson Presents $100,000 Grant for SF Disaster Preparedness & Neighborhood Emergency Response Training (NERT) Program   Mar 08, 06 17:05 ET Johnson & Johnson Announces Stock Repurchase Program   Mar 01, 06 10:30 ET Johnson & Johnson To Participate In The 26th Annual Cowen & Company Health Care Conference   Feb 17, 06 17:03 ET Johnson & Johnson Completes Acquisition of Animas Corporation   Feb 13, 06 11:02 ET Charles Prince of Citigroup Elected to Johnson & Johnson Board of Directors   Feb 01, 06 14:00 ET Johnson & Johnson to Participate in Merrill Lynch Conference   Jan 25, 06 07:10 ET Johnson & Johnson Statement Regarding Guidant Corporation   Jan 24, 06 08:10 ET Johnson & Johnson Reports Full-Year and Fourth-Quarter 2005 Results   Jan 19, 06 08:43 ET DePuy Orthopaedics Concludes Acquisition of Hand Innovations LLC   Jan 18, 06 10:00 ET Johnson & Johnson to Review Fourth-Quarter and Full-Year 2005 Financial Results   Jan 17, 06 16:58 ET Johnson & Johnson Statement Regarding Guidant Corporation Acquisition   Jan 13, 06 19:05 ET Guidant Corporation and Johnson & Johnson Announce New Definitive Acquisition Agreement   Jan 11, 06 19:14 ET Guidant Corporation and Johnson & Johnson Announce New Definitive Acquisition Agreement   Jan 08, 06 18:09 ET Johnson & Johnson Reaffirms Commitment to Guidant Acquisition   Jan 03, 06 14:19 ET Scios Submits Interim Report to FDA on NATRECOR(R)(nesiritide) PROACTION Trial   Dec 28, 05 16:24 ET Johnson & Johnson and Guidant Corporation Proposed Merger Registration Statement Declared Effective   Dec 21, 05 16:41 ET Personal Products Company Completes Acquisition of REMBRANDT(R) Brand From The Gillette Company   Dec 16, 05 08:58 ET Johnson & Johnson Announces Definitive Agreement to Acquire Animas Corporation, an Insulin Delivery Company   Dec 06, 05 09:43 ET Johnson & Johnson Files Form S-4 Registration Statement Regarding Acquisition of Guidant Corporation   Nov 22, 05 10:30 ET Johnson & Johnson to Participate in Fifth Annual Merrill Lynch Med Tech Fundamentals Conference   Nov 15, 05 07:03 ET Johnson & Johnson and Guidant Corporation Announce Revised Acquisition Agreement with Net Value of $19 Billion   Nov 07, 05 10:26 ET Johnson & Johnson Statement Regarding Guidant Corporation Civil Suit   Nov 03, 05 15:12 ET Johnson & Johnson to Participate in CIBC World Markets Sixteenth Annual Health Care Conference   Nov 02, 05 09:34 ET Johnson & Johnson Receives FTC Clearance of Proposed Acquisition of Guidant Corporation and Provides Update on Transaction in Light of Guidant Recall Events   Oct 24, 05 07:50 ET Personal Products Company to Acquire Rembrandt Brand from The Gillette Company   Oct 18, 05 08:03 ET Johnson & Johnson Reports 2005 Third-Quarter EPS Rose 11.5% on Sales Increase of 6.6%   Oct 12, 05 15:11 ET Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Results   Oct 04, 05 11:02 ET Johnson & Johnson Announces Appointment of Louise Mehrotra As Vice President, Investor Relations   Sep 07, 05 11:55 ET Johnson & Johnson to Participate in the 18th Annual Bear Stearns 2005 Health Care Conference   Sep 02, 05 09:52 ET Johnson & Johnson Advised by Canadian Competition Bureau on Proposed Acquisition of Guidant Corporation   Aug 25, 05 07:10 ET Johnson & Johnson Announces European Commission Clearance of Guidant Acquisition   Aug 02, 05 16:47 ET Johnson & Johnson Adopts PhRMA Guidelines on Direct-to-Consumer Advertising   Jul 20, 05 14:55 ET Scios Inc. Receives Subpoena on NATRECOR(R) (Nesiritide)   Jul 19, 05 16:44 ET Scios Inc. Announces Redemption of 5.50% Debentures Due August 2009   08:07 ET Johnson & Johnson Reports 2005 Second-Quarter Sales Increase of 11.1% and EPS of $.89 Versus $.82 a Year Ago; Excluding In-Process Research and Development Charges and Revised Tax Impact of American Jobs Creation Act, EPS Increased 13.4%*   Jul 12, 05 14:23 ET Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results   Jul 01, 05 17:09 ET Cordis to Ask Judge to Overturn Patent Verdict   Jun 30, 05 16:15 ET Johnson & Johnson Completes Acquisition of Peninsula Pharmaceuticals, Inc.   Jun 21, 05 13:46 ET Jury Finds Cordis Patents Infringed by Boston Scientific Stents   Jun 17, 05 16:20 ET Johnson & Johnson Statement Regarding Guidant Transaction   Jun 03, 05 13:43 ET Johnson & Johnson Completes Acquisition of CLOSURE Medical Corporation   May 24, 05 11:58 ET Johnson & Johnson Statement Regarding Guidant Transaction   May 19, 05 15:11 ET Johnson & Johnson to Host Pharmaceutical Research and Development Review   Apr 29, 05 15:08 ET Johnson & Johnson to Participate in Morgan Stanley Conference   Apr 28, 05 10:16 ET Johnson & Johnson Announces Dividend Increase of 15.8%   Apr 22, 05 16:52 ET Johnson & Johnson Proposed Acquisition of Guidant Corporation Enters Second Phase Review by European Commission   Apr 21, 05 11:05 ET Johnson & Johnson to Host Annual Meeting of Shareholders   Apr 19, 05 08:10 ET Johnson & Johnson - The World's Most Broadly Based Health Care Company Reports 2005 First-Quarter EPS Rose 16.9% on Sales Increase of 11.0%   07:44 ET Johnson & Johnson Announces Agreement to Acquire Peninsula Pharmaceuticals, Inc.   Apr 13, 05 14:47 ET Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results   Apr 05, 05 08:31 ET U.S. Pharmaceutical and Biotechnology Companies of Johnson & Johnson Participate in Partnership for Prescription Assistance   Apr 04, 05 18:31 ET Johnson & Johnson Completes Acquisition of TransForm Pharmaceuticals, Inc.   Mar 30, 05 16:06 ET DePuy Orthopaedics, Inc. Receives Subpoena   Mar 24, 05 15:18 ET Johnson & Johnson and Guidant Corporation Proposed Merger Registration Declared Effective   Mar 22, 05 14:39 ET New Partnership to Address Unique and Growing Needs of Women and Families Affected by HIV/AIDS   Mar 14, 05 10:59 ET Michael M.E. Johns, M.D. of Emory University Nominated for Election to the Johnson & Johnson Board of Directors   Mar 09, 05 09:02 ET Johnson & Johnson to Acquire TransForm Pharmaceuticals   Mar 04, 05 08:32 ET Johnson & Johnson and CLOSURE Medical Corporation Announce Acquisition Agreement   Mar 01, 05 16:45 ET Cordis to Host Analyst Meeting to Review REALITY Trial Results   Feb 18, 05 14:39 ET Johnson & Johnson and Guidant Corporation Will Respond to Federal Trade Commission's Request For Information   Feb 03, 05 11:26 ET Johnson & Johnson to Participate in Merrill Lynch Conference   Jan 25, 05 08:18 ET Johnson & Johnson - The World's Most Broadly Based Health Care Company 2004 Fourth-Quarter Sales Increased 13.3% Tax Impact of American Jobs Creation Act Reduced Fourth-Quarter Earnings 2004 Full Year EPS Rose 18.3% on Sales Increase of 13.1%   Jan 18, 05 14:36 ET Johnson & Johnson To Review Fourth-Quarter Results   Jan 12, 05 10:49 ET Christine A. Poon Appointed a Vice Chairman of Johnson & Johnson   Dec 23, 04 16:40 ET U.S. District Court Upholds LEVAQUIN(R) Patent   Dec 16, 04 00:15 ET Johnson & Johnson and Guidant Announce Definitive Agreement Valued at $23.9 Billion Based on $76 per Share   Dec 01, 04 08:41 ET Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Discontinues Clinical Development Program for Controlled Release Formulation of Topiramate In Obesity and Diabetes   Oct 26, 04 16:12 ET Johnson & Johnson to Host Analyst Meeting to Discuss Approval of the CHARITE(TM) Artificial Disc   15:11 ET FDA Approves First Artificial Disc for Treatment of Low Back Pain   Oct 12, 04 08:03 ET Johnson & Johnson 2004 Third-Quarter   Oct 08, 04 09:01 ET Johnson & Johnson Consumer France S.A.S. Completes Acquisition of Biapharm SAS   Oct 06, 04 14:22 ET Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Earnings   Oct 01, 04 17:48 ET Ortho Biotech Products, L.P. Receives Subpoena on PROCRIT(R)   17:05 ET Johnson & Johnson Announces Redemption of 8.72% Debentures Due November 2024   Sep 30, 04 11:43 ET ASAN Medical Center Study Suggests Differences in Drug-Eluting Stents in Patients with Advanced Coronary Artery Disease   Sep 28, 04 12:30 ET Johnson & Johnson Establishes $5 Million Hurricane Relief Fund   Sep 27, 04 08:31 ET Cordis Announces First Patient Enrolled in Surveillance Study of Carotid Artery Stenting System   Sep 24, 04 11:52 ET New Data on the Clinical Performance of the CYPHER Stent In Long Lesions, Diabetics and Other Complex Cases to Be Presented at TCT 2004   Sep 23, 04 09:30 ET Up to 6.5 Million U.S. Women Could Benefit from New Heart Health Advance   Sep 07, 04 16:10 ET Johnson & Johnson to Participate in the '17th Annual Bear Stearns 2004 Health Care Conference'   Aug 27, 04 10:10 ET Johnson & Johnson Consumer France SAS to Acquire Biapharm SAS   Jul 13, 04 08:15 ET Johnson & Johnson Reports 2004 Second-Quarter Sales Increase of 11.1% and EPS of $.82 Versus $.40 a Year Ago; Excluding In-Process Research and Development Charges, EPS Increased 17.1%   Jul 07, 04 14:11 ET Johnson & Johnson to Host Analyst Meeting to Discuss Second-Quarter Financial Results and Review Its Pharmaceuticals Business   Jun 02, 04 18:14 ET FDA Advisory Panel Unanimously Recommends DePuy Spine CHARITE(TM) Artificial Disc for Approval   May 28, 04 16:41 ET Cordis Corporation Statement on Litigation with Boston Scientific   May 27, 04 10:22 ET Diabetic Patients Among Broad Patient Group Found to Benefit From Treatment With the CYPHER(R) Sirolimus-eluting Coronary Stent   May 25, 04 12:50 ET New Clinical Data Shows Outstanding Performance of CYPHER(R) Sirolimus-eluting Coronary Stent in Highly Challenging Patient Cases   12:12 ET Studies About Artificial Disc Technology Prominent at Spine Arthroplasty Meeting in Vienna   May 13, 04 11:00 ET Johnson & Johnson to Participate in The Banc of America Securities Health Care Conference 2004   May 07, 04 12:33 ET Cordis Announces Nationwide Recall of Revised Instructions for Use for the PRECISE(R) RX Biliary Stent Contained in Its Medical Device Notification Dated March 29, 2004   Apr 29, 04 10:30 ET Johnson & Johnson to Participate in the '29th Annual Deutsche Bank Securities, Inc., 2004 Health Care Conference'   Apr 22, 04 11:22 ET Johnson & Johnson Companies Will Offer Medicines Free to Low-Income Medicare Beneficiaries Enrolling in Many CMS-Endorsed Drug Cards   10:53 ET Johnson & Johnson Announces Dividend Increase of 18.8%   Apr 21, 04 21:47 ET Cordis Endovascular's Carotid Stent System Recommended for Approval by FDA Advisory Panel   Apr 15, 04 10:30 ET Johnson & Johnson to Host Annual Meeting of Shareholders   Apr 13, 04 08:03 ET Johnson & Johnson 2004 First-Quarter EPS Rose 20.3% on Sales Increase of 17.7%   Apr 07, 04 15:09 ET Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results   Apr 02, 04 19:10 ET Cordis Cardiology Issues Statement Regarding GMP Observations   Mar 31, 04 10:52 ET CYPHER(R) Sirolimus-eluting Coronary Stent Approved for Marketing in Japan   Mar 18, 04 07:45 ET DePuy Spine CHARITE (TM) Artificial Disc Clinical Trial Results Presented at Major Spine Scientific Meeting   Mar 15, 04 11:46 ET CYPHER(R) Sirolimus-eluting Coronary Stent on Track for Approval in Japan   11:24 ET DePuy Orthopaedics Trauma & Extremities Group to Meet Needs of Specialty Surgeons   Mar 11, 04 09:30 ET Long-term Database Shows Sustained, Outstanding Performance of CYPHER(TM) Sirolimus-eluting Coronary Stent   Mar 08, 04 07:31 ET Study Shows CYPHER(TM) Sirolimus-eluting Coronary Stent Yields Strong Results Without Pre-dilatation   Mar 03, 04 13:13 ET Johnson & Johnson to Host DePuy Analyst Meeting   10:04 ET First Data from Head-to-Head Trial of Drug-eluting Coronary Stents Show Equivalent Deliverability   Feb 27, 04 07:48 ET Johnson & Johnson to Acquire Merck & Co., Inc.'s Interest in European Consumer Pharmaceuticals Joint Venture   Feb 24, 04 07:04 ET Cordis Corporation Announces Strategic Alliance with Guidant Corporation to Combat Coronary Artery Disease   Feb 19, 04 09:05 ET McNeil Nutritionals and Tate & Lyle Announce Strategic Realignment of Sucralose Alliance   Feb 18, 04 11:33 ET Enrollment Complete in First Randomized Head-to-Head Trial Of Drug-eluting Coronary Stents   Feb 17, 04 12:11 ET DePuy Spine Files FDA Application for CHARITE(TM) Artificial Disc   Feb 05, 04 09:18 ET Janssen Pharmaceutica and The Plaintiffs Steering Committee of the PROPULSID Multi-District Litigation Announce Agreement to Resolve Federal Cases   Feb 02, 04 13:48 ET Whitehead Institute for Biomedical Research Director Susan Lindquist Elected to Johnson & Johnson Board of Directors   Jan 29, 04 11:22 ET Johnson & Johnson to Participate in Merrill Lynch Conference   Jan 23, 04 16:51 ET Janssen Pharmaceutica Products, L.P. Receives Subpoena on Risperdal(R)   Jan 22, 04 15:33 ET Johnson & Johnson to Participate in The U.S. Bancorp Piper Jaffray 16th Annual Health Care Conference   Jan 20, 04 15:04 ET CYPHER(TM) Sirolimus-eluting Coronary Stent: Delivers on Clinical Promise   08:25 ET Johnson & Johnson 2003 Fourth-Quarter EPS Rose 34.8% on Sales Increase Of 19.7% 2003 EPS Rose 11.1% on Sales Increase of 15.3%   Jan 19, 04 14:37 ET 15,000-Patient Interventional Cardiology Registry to Evaluate Impact of Drug-Eluting Coronary Stents   Jan 15, 04 12:06 ET James T. Lenehan Retires From Johnson & Johnson   Jan 14, 04 16:49 ET Johnson & Johnson to Review Fourth-Quarter Results   Jan 09, 04 10:43 ET DePuy Spine Acquires Minimally Invasive Spinal Portfolio Assets From The Bright Group, Inc.   Dec 12, 03 11:01 ET Ortho-McNeil Pharmaceutical, Inc. Receives Subpoena on TOPAMAX(R)   Nov 21, 03 19:50 ET Johnson & Johnson Statement on Litigation with Boston Scientific   Nov 18, 03 09:03 ET Johnson & Johnson Pharmaceutical Research & Development L.L.C. Receives FDA Approvable Letter for Migraine Prophylaxis Indication for TOPAMAX(R)   Oct 14, 03 15:51 ET PepsiCo Chairman & Chief Executive Steven S Reinemund Elected to Johnson & Johnson Board of Directors   08:05 ET Johnson & Johnson 2003 Third Quarter EPS Rose 21.1% on Sales Increase of 15.2%   Oct 07, 03 14:34 ET Johnson & Johnson to Host Analyst Conference Call on Third Quarter Earnings   Sep 19, 03 20:56 ET Johnson & Johnson * Merck Consumer Pharmaceuticals Co. Statement on U.S. District Court Decision   Sep 10, 03 16:04 ET Restenosis Rates Drop to 5.1% In CYPHER(TM) Sirolimus-eluting Coronary Stent Trials   10:18 ET Johnson & Johnson to Webcast Cordis Analyst Meeting on September 16, 2003   Sep 08, 03 14:59 ET University of Michigan President Mary Sue Coleman Elected to Johnson & Johnson Board of Directors   Sep 04, 03 15:29 ET S.M.A.R.T.(R) Stent Receives FDA Approval for Treatment of Iliac Artery Disease   Sep 01, 03 06:00 ET CYPHER(TM) Sirolimus-Eluting Coronary Stent Demonstrates Dramatic Improvement in Patient Results in Second European Clinical Study   Aug 20, 03 11:28 ET Johnson & Johnson Awarded $425 Million In Patent Infringement Arbitration With Guidant   Jul 15, 03 08:22 ET Johnson & Johnson 2003 Second Quarter Sales Increased 13.9% EPS Decreased 25.9%; Excluding Special Charges, EPS Increased 16.7%   Jul 08, 03 11:29 ET Johnson & Johnson to Host Analyst Meeting to Discuss Second Quarter Financial Results and Review Its Pharmaceuticals Business   Jun 03, 03 15:54 ET DePuy AcroMed, Inc. Completes Acquisition of Link Spine Group, Inc.   Jun 02, 03 13:29 ET Ortho-Clinical Diagnostics Announces 510(k) Clearance for Ortho ProVue(TM)   May 29, 03 10:53 ET Johnson & Johnson to Host and Webcast Cordis Franchise Review   May 06, 03 17:09 ET DePuy Acromed, Inc. to Acquire Link Spine Group, Inc.   Apr 29, 03 12:47 ET Johnson & Johnson Completes Acquisition of Scios Inc.   Apr 24, 03 10:18 ET Johnson & Johnson Announces Dividend Increase of 17.1%   10:03 ET FDA Approves Landmark Treatment for Coronary Artery Disease   Apr 17, 03 15:23 ET Johnson & Johnson to Host Annual Meeting of Shareholders   Apr 15, 03 08:04 ET Johnson & Johnson 2003 First Quarter EPS Rose 16.9% on Sales Increase of 12.3%   Apr 10, 03 11:25 ET Johnson & Johnson to Host Analyst Conference Call On First-Quarter Earnings   Apr 03, 03 09:19 ET Johnson & Johnson and Scios Inc. Announce Early Termination Of Hart-Scott-Rodino Waiting Period   Mar 29, 03 10:26 ET CYPHER(TM) Sirolimus-Eluting Coronary Stent Reveals Encouraging Results In Second Randomized Clinical Study   Mar 28, 03 14:06 ET Johnson & Johnson Completes Acquisition of 3-Dimensional Pharmaceuticals, Inc.   Mar 13, 03 13:48 ET Johnson & Johnson to Participate in the 23rd Annual SG Cowen Health Care Conference   Feb 25, 03 09:01 ET Application Submitted to FDA for Once-Daily Formulation of REMINYL(R), Treatment for Alzheimer's Disease   Feb 10, 03 17:43 ET Johnson & Johnson Completes Acquisition of OraPharma, Inc.   08:46 ET Johnson & Johnson to Acquire Scios Inc.; Cash for Stock Transaction Valued at $2.4 Billion   Jan 29, 03 11:46 ET DePuy, Inc. Acquires Certain Assets of Orquest, Inc. Further Expands Orthobiologic Product Portfolio and Pipeline   Jan 28, 03 16:25 ET Johnson & Johnson to Participate in The Merrill Lynch Global Pharmaceuticals, Biotechnology & Medical Devices Conference '2003: Innovation Still Counts'   13:39 ET DePuy, Inc. Announces Exclusive Worldwide License for Bone Morphogenic Protein Technology from Biopharm, GmbH   Jan 24, 03 18:51 ET Johnson & Johnson Statement on Arbitration Fees and Expenses   Jan 23, 03 15:05 ET Johnson & Johnson to Participate in The U.S. Bancorp Piper Jaffray 15th Annual Health Care Conference   Jan 21, 03 08:21 ET Johnson & Johnson Excluding Special Charges 2002 Fourth Quarter EPS Rose 23.1% on Sales Increase of 14.3% 2002 EPS Rose 17.3% on Sales Increase of 12.3%   Jan 16, 03 08:03 ET Johnson & Johnson to Acquire 3-Dimensional Pharmaceuticals, Inc.   Jan 15, 03 10:21 ET Johnson & Johnson to Host Analyst Meeting And Webcast on Fourth-Quarter Earnings   Dec 16, 02 09:01 ET Application Submitted To FDA For Risperdal(R) Treatment of Bipolar Disorder   Dec 09, 02 13:34 ET Dr. Nancy Snyderman, M.D., Joins Johnson & Johnson As Vice President, Medical Affairs   Dec 06, 02 14:26 ET Johnson & Johnson to Participate in The Banc of America Securities Healthcare Forum: 'A Look Back, A Look Forward'   Dec 02, 02 14:32 ET Intravenous Administration Required When Using EPREX/ERPYO (epoetin alfa) in Chronic Renal Failure Patients   06:31 ET Janssen-Cilag Initiates EPREX /ERYPO Labeling Change in Consultation With French Health Authority   Nov 18, 02 16:30 ET Cordis Corporation Reports Positive Results In Bifurcation Feasibility Study For Cypher(TM) Sirolimus-Eluting Stent   Nov 13, 02 09:03 ET Johnson & Johnson to Acquire OraPharma, Inc.   Nov 05, 02 15:22 ET Johnson & Johnson to Participate in Third Annual Merrill Lynch Med Tech Fundamentals Conference   Nov 01, 02 08:30 ET Application Submitted to FDA for Topamax(R) Monotherapy Treatment of Epilepsy   Oct 22, 02 21:39 ET Cordis Corporation's Drug-Eluting Stent Receives Unanimous Recommendation From FDA Advisory Panel   Oct 18, 02 17:59 ET Johnson & Johnson Statement on Amgen Arbitration   Oct 15, 02 08:07 ET Johnson & Johnson Excluding Special Charges 2002 Third Quarter EPS Rose 20.0% Sales Increased 12.7%   Oct 08, 02 16:22 ET Johnson & Johnson to Host Analyst Conference Call On Third Quarter Earnings   Sep 24, 02 10:30 ET Final Results of Large-Scale U.S. Study Confirm Positive Performance Of Cordis CYPHER(TM) Sirolimus-eluting Stent   Sep 19, 02 16:15 ET Cordis to Host Analyst Meeting At Transcatheter Cardiovascular Therapeutics Symposium   Sep 18, 02 15:26 ET Johnson & Johnson to Host Business Review Focusing on Technology Driven Growth   Sep 09, 02 08:32 ET Johnson & Johnson Pharmaceutical Research & Development Announces Positive Phase III Findings for Two New Topamax(R) Indications; Says It Will Not Pursue a Third   Sep 04, 02 14:53 ET Johnson & Johnson to Participate in Bear Stearns 'Meet the Experts' Panel Discussion on PROCRIT/EPREX   Aug 26, 02 17:17 ET Johnson & Johnson Statement on Puerto Rico Lawsuit   11:12 ET Nitinol-Based, Self-Expanding, Crush-Recoverable Stent for Biliary Blockages   Jul 31, 02 14:45 ET Drug-eluting Stents to Receive Incremental Reimbursement   Jul 19, 02 14:35 ET Johnson & Johnson Statement   Jul 16, 02 08:09 ET Johnson & Johnson Excluding Special Charges 2002 Second Quarter EPS Rose 17.6% Sales Increased 10.9%   Jul 09, 02 16:30 ET Johnson & Johnson Analyst Meeting On Second Quarter Earnings   Jul 01, 02 07:01 ET Johnson & Johnson Pharmaceutical Research & Development Receives Non-Approvable Letter for Risperdal Consta   May 16, 02 15:32 ET Johnson & Johnson Will Host Financial Analysts Meeting - Wednesday, May 22, 2002 At Paris Course On Revascularization (PCR) - Paris, France   May 02, 02 15:00 ET Johnson & Johnson to Participate in the Deutsche Banc Alex. Brown Inc. '2002 Health Care Conference'   Apr 25, 02 10:41 ET Johnson & Johnson Announces Dividend Increase of 13.9%   Apr 18, 02 15:17 ET Johnson & Johnson to Host Annual Meeting of Shareowners   14:04 ET Johnson & Johnson Completes Acquisition of Tibotec-Virco   Apr 17, 02 11:06 ET Former U.S. Surgeon General David Satcher Elected to Johnson & Johnson Board   Apr 16, 02 08:08 ET Johnson & Johnson 2002 First Quarter Net Earnings Rose 18.2% Sales Increased 11.3% EPS Rose 18.0%   Apr 15, 02 12:11 ET Cordis' CYPHER(TM) Sirolimus-eluting Stent Receives CE Mark Approval   06:00 ET Cordis' CYPHER(TM) Sirolimus-eluting Stent Receives CE Mark Approval   Apr 09, 02 15:57 ET Johnson & Johnson to Host Analyst Meeting on First-Quarter Earnings   Mar 22, 02 06:30 ET Johnson & Johnson to Acquire Tibotec-Virco   Mar 18, 02 14:58 ET Ortho-Clinical Diagnostics, Inc. Announces Acquisition of Micro Typing Systems, Inc.   Mar 17, 02 17:00 ET Three Clinical Studies Using CYPHER(TM) Sirolimus-eluting Stent Demonstrate Unprecedented Results in Coronary Artery Disease   Mar 01, 02 18:06 ET Johnson & Johnson Applauds President's Medicare Drug Plan   Feb 13, 02 12:03 ET Johnson & Johnson Announces Stock Repurchase Program   Feb 01, 02 15:42 ET Johnson & Johnson to Participate in The Merrill Lynch Global Pharmaceuticals, Biotechnology & Medical Devices Conference '2002: A Balancing Act'   Jan 24, 02 12:35 ET First Long-Term Health and Wellness Program Evaluation Confirms Employee Benefit, Company Savings for Johnson & Johnson   Jan 22, 02 09:43 ET William C. Weldon to Succeed Ralph S. Larsen As Chairman and CEO of Johnson & Johnson   08:36 ET Johnson & Johnson Excluding Special Charges 2001 Fourth Quarter EPS Rose 21.9% on Sales Increase of 15.1% 2001 EPS Rose 17.2% on Sales Increase of 10.6%   Jan 16, 02 15:51 ET Johnson & Johnson to Host Analysts Meeting And Conference Call on Fourth Quarter Earnings   Dec 18, 01 15:44 ET Cordis Corporation Acquires TERAMed, Inc. for Proprietary Technology to Treat Abdominal Aortic Aneurysms   Dec 13, 01 09:02 ET Americans Awake and Worried - Personal Finance More Disconcerting Than National Security Issues -   Nov 21, 01 17:37 ET Johnson & Johnson Completes Acquisition of Inverness Medical Technology's Diabetes Care Products Business   14:00 ET Johnson & Johnson to Participate in The Second Annual Merrill Lynch Med Tech Fundamentals Conference   Nov 16, 01 12:58 ET New Brunswick Scientific Organizes Conference on New Methods for Producing Low-Cost, Vaccines for Developing Nations   12:37 ET Johnson & Johnson Announces Tentative Closing Date for Proposed Acquisition of Inverness Medical Technology, Inc.   Nov 13, 01 11:11 ET Four-Month Pilot Study Findings Released   Oct 29, 01 14:08 ET Bx VELOCITY(TM) Coronary Stent with HEPACOAT(TM) Now Available with Rapid Exchange Delivery System   Oct 24, 01 18:18 ET Johnson & Johnson Confirms It Seeks Anthrax Indication for LEVAQUIN; Pledges Contribution of 100 Million Tablets to HHS   Oct 22, 01 12:42 ET Johnson & Johnson and Inverness Medical Technology Announce Effectiveness of Registration Statements   Oct 16, 01 08:08 ET Johnson & Johnson Excluding Special Charges 2001 Third Quarter Net Earnings Rose 17.4%; Sales Increased 10.8%; EPS Rose 16.3%   Oct 09, 01 10:31 ET Johnson & Johnson to Host Conference Call on Third-Quarter Earnings   Sep 24, 01 11:33 ET Johnson & Johnson to Webcast Cordis Presentation to Analysts   Sep 21, 01 12:08 ET Johnson & Johnson to Participate in Bear Stearns 2001 Health Care 'Virtual' Conference   Sep 17, 01 17:31 ET Johnson & Johnson Note to Editors   11:45 ET The R.W. Johnson Pharmaceutical Research Institute Announces Results Of Studies With Topiramate in Diabetic Neuropathic Pain   Sep 06, 01 12:38 ET Johnson & Johnson to Participate in 14th Annual Bear Stearns, 2001 Health Care Conference   Sep 04, 01 07:34 ET 'Zero' Restenosis in 'RAVEL' Landmark European Multi-Center Clinical Trial Of CYPHER(TM) Sirolimus-eluting Stent   Aug 30, 01 15:38 ET Cordis Completes Enrollment in Landmark U.S. Trial   Aug 29, 01 17:11 ET Form S-4 for Johnson & Johnson and Inverness Medical Technology's Transaction to be Reviewed by the SEC   13:12 ET Johnson & Johnson to Host Medical Devices & Diagnostics Business Review   Jul 27, 01 12:33 ET Vistakon and Plaintiffs Reach Settlement of Class Action Lawsuit Concerning Acuvue(R) and 1-Day Acuvue(R)   Jul 20, 01 16:12 ET Johnson & Johnson and Inverness Medical Technology Announce Early Termination Of Hart-Scott-Rodino Waiting Period and Clearance From German Authorities   Jul 17, 01 08:21 ET Johnson & Johnson Excluding Special Charges 2001 Second Quarter EPS Rose 15.9%; Sales Increased 8.8%; Net Earnings Rose 16.2%   Jul 02, 01 10:30 ET Johnson & Johnson Announces Redemption Of Heartport 7.25% Convertible Notes Due May 2004   Jun 22, 01 10:13 ET Johnson & Johnson Announces Completion of Merger with ALZA Corporation   Jun 20, 01 09:01 ET Johnson & Johnson and ALZA Corporation Announce Tentative Closing Date For Proposed Merger   Jun 12, 01 08:06 ET St. Joseph(R) 81mg Aspirin Returns to the Heart of America; 110 Year-Old Brand to Be Re-launched Nationally in St. Joseph, Missouri   May 25, 01 09:45 ET Johnson & Johnson to Host Pharmaceutical Business and Research & Development Review   May 23, 01 11:00 ET Johnson & Johnson Agrees to Acquire Inverness Medical Technology's Diabetes Care Products Business in $1.3 Billion Stock-for-Stock Transaction   May 22, 01 13:22 ET Johnson & Johnson Vision Care, Inc. Resolves Contact Lens Antitrust Litigation   May 21, 01 15:14 ET New Study Finds Nocturnal Acid Breakthrough Better Controlled With OTC Combination Heartburn Product Than Second Dose of Prescription PPI   May 15, 01 08:52 ET Johnson & Johnson and ALZA Corporation Announce Effectiveness of Registration Statement for Their Proposed Merger   May 10, 01 13:01 ET Johnson & Johnson and ALZA Corporation Announce Early Termination of Hart-Scott-Rodino Waiting Period   May 09, 01 18:59 ET Johnson & Johnson and Inverness Medical Technology In Discussions for Johnson & Johnson to Acquire Inverness's Diabetes Care Products Business In $1.3 Billion Stock for Stock Transaction   08:03 ET U.S. Labeling Changes Announced for SPORANOX (itraconazole)   May 03, 01 14:31 ET Johnson & Johnson to Participate in The Deutsche Banc Alex. Brown Inc., '2001 Health Care Conference'   Apr 26, 01 10:34 ET Johnson & Johnson Announces 2-for-1 Stock Split and Dividend Increase of 12.5%   Apr 18, 01 17:28 ET Johnson & Johnson Announces Completion of Merger with Heartport, Inc.   Apr 17, 01 07:36 ET Johnson & Johnson 2001 First Quarter EPS Rose 14.0%; Sales Increased 6.5%; Net Earnings Rose 14.2%   Apr 13, 01 11:37 ET Johnson & Johnson Conference Call on First-Quarter Earnings   Apr 06, 01 15:21 ET FDA Approves New Cordis Rapid Exchange Delivery System For Increased Versatility of its Bx Velocity(TM) Coronary Stent   Mar 27, 01 07:34 ET Johnson & Johnson to Merge With ALZA Corporation In $10.5 Billion Stock-for-Stock Transaction   Mar 02, 01 10:24 ET Johnson & Johnson Acquires BabyCenter From eToys, Inc. Leading Online Destination for Parents Plans for Continued Expansion of Operations   Feb 13, 01 09:45 ET Johnson & Johnson Board Elects James T. Lenehan and William C. Weldon Vice Chairmen of the Board   Feb 08, 01 11:36 ET Cordis Coronary Stent Receives Broader Indication   Feb 05, 01 13:19 ET FDA Grants Conditional 'IDE' Approval to Cordis for Pivotal Clinical Study Of Sirolimus-Coated Bx VELOCITY(TM) Stents   Feb 02, 01 11:07 ET Johnson & Johnson to Participate in the Merrill Lynch Global Pharmaceuticals, Biotechnology & Medical Devices Conference '2001: A Healthcare Odyssey'   Jan 26, 01 09:00 ET Johnson & Johnson to Acquire Heartport, Inc.   Jan 24, 01 16:15 ET Johnson & Johnson to Participate In The U.S. Bancorp Piper Jaffray Health Care Conference   Jan 23, 01 08:28 ET Johnson & Johnson Fourth Quarter EPS Rose 16.1% on Sales Increase of 3.4% 2000 EPS Rose 15.2% on Sales Increase of 6.1%   Jan 17, 01 14:26 ET Johnson & Johnson to Host Analyst Meeting on Fourth-Quarter Earnings   Jan 04, 01 17:19 ET Johnson & Johnson Announces Redemption of Centocor 4.75% Convertible Debentures Due February 2005   Dec 27, 00 16:06 ET Johnson & Johnson Announces Acquisition of Atrionix, Inc.; Fourth Quarter One-Time Charge of Approximately $55 million   Dec 21, 00 17:47 ET Pilot Study Results of Cordis Sirolimus-Coated Bx Velocity(TM) Stent Reveal 'No Restenosis' in 45 Patients in Two Global Regions   Dec 15, 00 18:55 ET Johnson & Johnson Remains Comfortable With Analyst EPS Estimates For Full Year 2000   18:23 ET Statement on LifeScan's SURESTEP Meter   Nov 14, 00 08:30 ET First to Market with First Coated Stent: Cordis Introduces Bx Velocity(TM) 'Hepacoat(TM)' Stent - Heparin-Coated Care for Coronary Artery Disease   Nov 13, 00 11:23 ET Johnson & Johnson to Participate In Merrill Lynch Medical Technology Fundamentals Conference   Nov 06, 00 10:13 ET Cordis Receives FDA Approval for New Product To Treat Patients with In-Stent Restenosis   09:34 ET Cordis Receives FDA Approval for New Product To Treat Patients In-Stent Restenosis   Nov 03, 00 18:35 ET CHECKMATE(TM) System for Coronary Artery Disease - Cordis First to Market With New Product for Patients With In-Stent Restenosis   Oct 18, 00 18:59 ET Direct Clinical Trial Interim Results Presented At Annual 'TCT' Scientific Symposium   14:51 ET Bx VELOCITY(TM) Stent Study of 300 Patients With de novo Lesions   Oct 17, 00 10:17 ET Johnson & Johnson To Distribute Over One Million Free Copies of a Newsweek Magazine Special on Early Childhood Development   08:32 ET Johnson & Johnson 2000 Third Quarter EPS Rose 14.1%; Sales Increased 4.6%; Net Earnings Rose 13.8%   Oct 16, 00 18:12 ET Johnson & Johnson-Merck Receives FDA Approval for Pepcid Complete, A Unique New Way To Treat Heartburn   Sep 26, 00 15:56 ET FDA Approves Cordis Trufill(R) n-BCA Liquid Embolic Treatment System For Cerebral 'AVMs'   Jul 18, 00 08:13 ET Johnson & Johnson 2000 Second Quarter EPS Rose 14.6% Sales Increased 7.7% Net Earnings Rose 14.3%   Jun 28, 00 12:35 ET FDA Review Panel Unanimously Recommends Approval of Cordis Brachytherapy for Treating In-Stent Restenosis   May 18, 00 10:52 ET FDA Grants Marketing Release of Bx VELOCITY(TM) Coronary Artery Stent from Cordis Corporation   May 08, 00 14:44 ET Gamma-1: Major Cordis Clinical Trial Demonstrates Cost-Effectiveness of Gamma Radiation at One-Year Follow-up for Treating Clogged Stents in Coronary Arteries   May 01, 00 11:12 ET Business Council News Conference Wednesday, May 10, 2000 Economic Outlook Reports To Be Released   Apr 19, 00 10:46 ET Johnson & Johnson Announces Dividend Increase of 14.3%   Apr 18, 00 08:29 ET Johnson & Johnson 2000 First Quarter EPS Rose 16.3% Sales Increased 8.6% Net Earnings Rose 15.5%   Apr 04, 00 07:09 ET Cordis Enters Strategic Agreements with Guidant Corp. For Cardiovascular Devices and Therapies   Mar 14, 00 11:55 ET Gamma 2: Major Clinical Trial Presented at ACC Cites Safety and Efficacy Of Gamma Radiation For Treating Reclogged Stents in Coronary Arteries   Mar 13, 00 10:48 ET Arbitrator Issues Rulings Favorable to Johnson & Johnson In License Dispute with Amgen   Feb 11, 00 16:58 ET Johnson & Johnson Announces Completion of Merger with Innovasive Devices, Inc.   Jan 25, 00 08:29 ET Johnson & Johnson 1999 EPS Rose 13.8% on Sales Increase of 14.5% Fourth Quarter EPS Rose 12.0% on Sales Increase of 6.3%   Nov 19, 99 13:00 ET Statement from Johnson & Johnson Concerning Medicated Baby Powder   Nov 08, 99 21:29 ET Johnson & Johnson Announces the Acquisition of Innovasive Devices, Inc.   Oct 27, 99 17:08 ET Business Council Outlook: Faster Global Economic Activity in 2000 Slower Growth in the United States No Appreciable Change in U.S. Inflation   Oct 19, 99 08:29 ET Johnson & Johnson 1999 Third Quarter Sales Increased 17.9% Net Earnings Rose 14.4% EPS Rose 14.3%   Oct 06, 99 10:10 ET Johnson & Johnson Announces Completion of Merger with Centocor, Inc.   Oct 05, 99 10:08 ET Johnson & Johnson and Centocor Announce Stock Conversion Ratio for Proposed $4.9 Billion Merger   Sep 23, 99 14:15 ET GAMMA 1: Major Clinical Trial Cites Efficacy and Safety of Gamma Radiation At Nine Months for Treating Reclogged Stents in Coronary Arteries   Sep 15, 99 09:44 ET FDA Approves CrossFlex(TM)LC - New 'Workhorse' Coronary Artery Stent from Cordis Cardiology; Agility, Trackability, Versatility   Sep 07, 99 14:34 ET Johnson & Johnson and Centocor Announce Mailing of Proxy-Prospectus for Their Proposed $4.9 Billion Merger   Aug 31, 99 12:35 ET BENESTENT I: Five-Year Follow-Up Results of First Major European Randomized Clinical Trial Compares Efficacy of Coronary Stents vs. Angioplasty   Aug 30, 99 10:36 ET ARTS: Landmark Randomized Clinical Trial Compares Efficacy of Coronary Stents vs. Bypass Surgery For Treating Multivessel Coronary Artery Disease   Jul 21, 99 07:30 ET Johnson & Johnson to Merge with Centocor, Inc. For $4.9 Billion in Stock-for-Stock Transaction   Jul 20, 99 08:29 ET Johnson & Johnson 1999 Second Quarter Sales Increased 18.5%; Net Earnings Rose 14.9%; EPS Rose 13.5%   Jul 19, 99 16:01 ET Leo F. Mullin Elected to Johnson & Johnson Board   Jul 14, 99 09:30 ET Cordis Submits 'PMAA' to FDA for Catheter-Based GAMMA Radiation to Treat Advanced Coronary Artery Disease   Jul 07, 99 10:43 ET Cordis Acquires AngioGuard, Inc. for Proprietary Technology Protecting Brain & Heart During Interventional Procedures   Jul 01, 99 07:29 ET Johnson & Johnson Begins Clinical Trials on Investigational Advanced Mobility System for People with Disabilities   Jun 29, 99 07:00 ET Summer Heat Increases Likelihood of Athlete's Foot and Other Fungal Infections   Jun 21, 99 07:00 ET Proper Treatment of Atopic Dermatitis May Bring Relief for Children and Parents/Caregivers   Jun 10, 99 10:07 ET Biosense Webster Announces Collaboration with Vascular Genetics Inc. on Catheter Delivery of Gene Therapy to Treat Cardiac Disease   May 20, 99 16:16 ET Statement from Johnson & Johnson Medical, Arlington, Texas   May 19, 99 14:21 ET Biosense to Collaborate with Warner-Lambert on Catheter Delivery of Gene Therapy to Treat Heart Disease   May 18, 99 10:00 ET FDA Clears New PALMAZ(R) CORINTHIAN(TM) Transhepatic Biliary Stent and Delivery System   May 06, 99 17:00 ET Business Council Releases Survey Results: Economists and CEOs See Easing of Global Economic Slide;   Apr 28, 99 14:00 ET Business Council News Conference Thursday, May 6, 1999; Economic Outlook Reports to be Released   Apr 22, 99 10:17 ET Johnson & Johnson Announces Dividend Increase of 12.0%   Apr 20, 99 08:28 ET Johnson & Johnson 1999 First Quarter Sales Increased 14.8% EPS Rose 12.3% Net Earnings Rose 11.7%   Apr 19, 99 08:59 ET Cordis Cardiology Introduces the MINI Crown Stent   Mar 09, 99 12:50 ET Biosense and RPR Gencell Collaborate on Innovative Gene Therapy to Treat Heart Disease   Mar 08, 99 13:49 ET Gamma 1: Major Clinical Trial Cites Efficacy and Safety of Gamma Radiation for Treating Reclogged Stents in Coronary Arteries   Feb 26, 99 15:15 ET Johnson & Johnson Completes Acquisition of Dermatological Skin Care Business From S.C. Johnson & Son, Inc.   Feb 16, 99 09:33 ET Ortho-Clinical Diagnostics and Chiron Granted FDA Approval for New Hepatitis C Test; New Supplemental Test Offers Superior Performance   Jan 26, 99 08:30 ET Johnson & Johnson 1998 EPS Rose 10.8% on Sales Increase of 4.5%; Fourth Quarter EPS Rose 11.1% on Sales Increase of 13.1%   Jan 18, 99 08:17 ET Shiseido Co., Ltd. and Johnson & Johnson Form Strategic Alliance for Skin and Hair Care Products   Jan 07, 99 10:44 ET FDA Clears Cordis Endovascular S.M.A.R.T.(TM) Stent For Treating Biliary Obstructions   Dec 17, 98 08:20 ET Johnson & Johnson to Acquire Dermatological Skin Care Business From S.C. Johnson & Son, Inc.   Dec 03, 98 16:35 ET Johnson & Johnson to Realign its Global Manufacturing Network and Take After Tax Charge of $800 Million Against 4th Qtr. Earnings   Nov 17, 98 12:04 ET Statement by Johnson & Johnson Regarding The Death of Lisa Smart   Nov 09, 98 08:54 ET Johnson & Johnson Announces Completion of Its Tender Offer for FemRx, Inc.   Nov 06, 98 17:48 ET Statement to Editors re: New York State Department of Health Investigation   16:58 ET Johnson & Johnson Completes Sale of Critikon to Investment Group   Nov 05, 98 18:06 ET Johnson & Johnson Announces the Merger of its Wholly Owned Subsidiary with and into DePuy, Inc.   Oct 29, 98 19:47 ET Johnson & Johnson Announces Completion of Its Tender Offer for DePuy, Inc.   Oct 28, 98 13:19 ET Johnson & Johnson Receives Approval From the Commission of the European Union Required for the Acquisition of DePuy, Inc.   Oct 14, 98 17:12 ET Johnson & Johnson Announces Extension of Tender Offer for DePuy, Inc. to October 29   Oct 13, 98 08:29 ET Johnson & Johnson 1998 Third Quarter EPS Rose 11.1% on Sales Increase of 2.5% Net Earnings Rose 12.4%   Oct 05, 98 08:06 ET Johnson & Johnson to Acquire FemRx, Inc.   Sep 15, 98 17:50 ET Johnson & Johnson Announces European Union Antitrust Filing and Extension of Tender Offer for DePuy, Inc. to October 16   Sep 02, 98 11:00 ET Johnson & Johnson Announces Appointment of Helen E. Short as Vice President, Investor Relations   Aug 20, 98 08:00 ET Johnson & Johnson Announces Expiration of Hart-Scott-Rodino Antitrust Waiting Period and Extension of Tender Offer for DePuy, Inc. to October 5   Aug 04, 98 16:16 ET Johnson & Johnson Announces Hart-Scott-Rodino Antitrust Filing in Offer for DePuy, Inc.   Jul 21, 98 02:00 ET Johnson & Johnson to Acquire DePuy For $35.00 Per Share or $3.5 Billion   Jul 14, 98 08:30 ET Johnson & Johnson 1998 Second Quarter EPS Rose 10.4% on Sales Increase of 1.5%   Jun 08, 98 17:06 ET Johnson & Johnson Appoints R. G. Gelbman Worldwide Chairman Of Its Health Systems & Diagnostics Group; W. C. Weldon Named Worldwide Chairman, Pharmaceuticals Group   Jun 04, 98 12:53 ET LifeScan Announces Removal and Replacement of Certain SureStep Consumer Blood Glucose Meters   Apr 23, 98 13:37 ET Johnson & Johnson Outlines 'Platforms for Growth' Increases Dividend for 36th Consecutive Year   10:55 ET John W. Snow Elected to Johnson & Johnson Board   10:18 ET Johnson & Johnson Announces Dividend Increase of 13.6%   Apr 15, 98 08:50 ET Arbitrator Orders Amgen to Pay Ortho Biotech Approximately $205 Million   Apr 14, 98 08:31 ET Johnson & Johnson 1998 First Quarter EPS Rose 10.6% on Sales Increase of 1.2%; Net Earnings Rose 11.1%   Feb 11, 98 13:30 ET Cordis Acquires IsoStent Technology; Continues Collaborative Radioactive Stent Research   Feb 09, 98 16:01 ET M. Judah Folkman, M.D. Elected To Johnson & Johnson Board   Jan 20, 98 08:32 ET Johnson & Johnson 1997 EPS Rose 13.8% on Sales Increase of 4.7% Fourth Quarter EPS Rose 11.9% on Sales Increase of 2.3%1   Dec 22, 97 12:42 ET FDA Clears Palmaz-Schatz(R) Crown Stent For Coronary Patients   Nov 20, 97 08:30 ET Gynecare, Inc. Shareholders Approve Acquisition by Johnson & Johnson   Nov 04, 97 11:03 ET Cordis and Medtronic Settle Patent Dispute, Sign Cross-License for Stents and Stent Delivery Systems   Oct 24, 97 07:20 ET Johnson & Johnson Gains Marketing Rights to Novel Class of Compounds for Treating Pain and inflammation   Oct 16, 97 12:41 ET Cordis and Biosense Complete Merger   Oct 14, 97 08:29 ET Johnson & Johnson Third Quarter Earnings Increased 14.0%; Sales Increased 3.4%; Earnings Per Share Rose 14.3%   Sep 25, 97 10:47 ET Cordis and Biosense Sign Definitive Merger Agreement   Sep 17, 97 07:57 ET Tylenol(R) Brand Announces Kickoff of 1998 $600,000 National Scholarship Program; 510 Future Leaders Representing All 50 States to be Selected   Sep 11, 97 14:33 ET Henry B. Schacht Elected to Johnson & Johnson Board   Aug 04, 97 09:32 ET Johnson & Johnson and Gynecare, Inc. Agree to Stock-for-Stock Merger Valued at $79 Million   Jul 31, 97 16:47 ET Johnson & Johnson and Biopsys Medical, Inc. Complete Merger   Jul 15, 97 08:47 ET Johnson & Johnson Second Quarter Earnings Increased 14.9%; Sales Increased 5.9%; Earnings Per Share Rose 13.3%   Jun 26, 97 14:31 ET CONFIDE HIV Service Withdrawn from Market   May 22, 97 08:14 ET Johnson & Johnson and Biopsys Medical, Inc. Agree to Stock-for-Stock Merger Valued at Approximately $310 Million   May 07, 97 10:41 ET Newly Reported Research Confirms the First Three Years are Critical - Making the Most of Everyday Activities Helps Children Reach Their Full Potential   Apr 24, 97 10:30 ET Johnson & Johnson Announces Dividend Increase 15.8 Percent   Apr 15, 97 09:14 ET Eisai and Janssen Pharmaceutica Announce Strategic Alliance for New Proton Pump Inhibitor   08:32 ET Johnson & Johnson Announces Record Sales and Earnings; 1997 First Quarter EPS Rose 15.3 Percent on Sales Increase of 7.1 Percent   Mar 27, 97 14:00 ET Johnson & Johnson Names Robert J. Darretta Chief Financial Officer   Mar 18, 97 10:35 ET Johnson & Johnson Announces That More Than 94% of the Shares of Innotech, Inc. Have Been Accepted for Payment in its Tender Offer   Mar 17, 97 18:15 ET Direct Access Diagnostics and Elliott Millenson Settle Litigation   Mar 03, 97 22:16 ET Cordis Acquires Nitinol Development Corporation   10:31 ET Cordis Acquires Nitinol Development Corporation   Feb 28, 97 11:50 ET Johnson & Johnson Announces Clearance of Antitrust Review in Offer for Innotech, Inc.   Feb 18, 97 08:31 ET Ortho Diagnostics To Have Exclusive Supply Agreement With The American Red Cross   Feb 11, 97 08:45 ET Johnson & Johnson to Acquire Innotech, Inc. for $13.75 Per Share in Cash   Jan 24, 97 10:30 ET Boehringer Mannheim Corporation and Johnson & Johnson Settle Lawsuits   Jan 21, 97 08:30 ET Johnson & Johnson 1996 EPS Rose 16.7% on Sales Increase of 14.7%; Fourth Quarter Sales Increase 13.5%, Fourth Quarter EPS up 16.7%   Jan 09, 97 16:13 ET Johnson & Johnson and Cook Group Inc. Reach Settlement In Patent Dispute Over Balloon-Expandable Stents   Dec 12, 96 12:37 ET Janssen Statement on Comparative Study of Risperdal and Olanzapine December 12, 1996   Oct 16, 96 08:29 ET Johnson & Johnson Third Quarter Sales Increase 14%; Net Earnings Up 20.4%; Earnings Per Share Rose 16.7%   Oct 02, 96 10:22 ET Johnson & Johnson Celebrates National Dental Hygiene Month   Jul 16, 96 07:40 ET JOHNSON & JOHNSON SECOND QUARTER SALES INCREASED 13 PERCENT NET EARNINGS UP 19.7 PERCENT EARNINGS PER SHARE ROSE 17.6 PERCENT